Pharmahungary Group runs in-house R&D projects for the development of therapies in cardiovascular and metabolic diseases up to phase II clinical stage. Investors and co-development partners are welcome:
The following in-house diagnostic R&D projects of Pharmahungary Group are in the early clinical phase of development:
Pharmahungary Group bioinformatics tools are already available online: